Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Warning
Sort By
Newest First
1 / 1
1 / 1
Drug Risk
FDA Approves Boxed Warning About Increased Risk of Blood Clots and Death with Higher Dose of Xeljanz
U.S. Food & Drug Administration
PR-M07-19-NI-074
Jul 29, 2019